Postoperative Pain Management After Minimally Invasive Esophagectomy
Phase 4
- Conditions
- Esophageal Cancer
- Interventions
- Other: combined paravertebral infusion and single shot of TAP blockOther: continuous epidural infusion
- Registration Number
- NCT02042313
- Lead Sponsor
- Sun Yat-sen University
- Brief Summary
Esophagectomy is a major surgical procedure often associated with significant morbidity and mortality and significant level of postoperative pain. In contrast to open esophagectomy where epidural pain control has been considered as a gold standard and could be crucial in affecting outcome the analgesic scheme for minimally invasive esophagectomy (MIE) is yet to be established. We would like to compare continuous epidural analgesia and continuous paravertebral block combined with single shot subcostal transversus abdominis plane (TAP) block in the analgesic effects, levels of cytokines, and postoperative complications in patients receiving MIE.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
- Patient has a physical status between ASA I and III
- 20 - 75 years of age
- Patient has signed an informed consent
- Without contraindication of GA, EA or PVB
Exclusion Criteria
- ASA > III
- Inability to provide informed consent
- Bleeding disorders
- Being pregnant
- Contraindications to nonsteroidal anti-inflammatory drugs (NSAIDs),
- Allergy to amide-type local anesthetics or NSAIDs
- Infection at the thoracic paravertebral injection site
- Severe spine or chest wall deformity
- Patients with major psychosis or drug and alcohol abuse
- Patients with a history of significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic disease
- Patients with physical disability that precludes complete cooperation
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description combined PVB TAP combined paravertebral infusion and single shot of TAP block Paravertebral catheterization into the paravertebral region ipsilateral to the VATS incision as described by Murata at the level of T7-8 will be performed. 10 ml of 2% xylocaine with 1 in 200,000 epinephrine to initiate analgesia. During the surgery, 2% xylocaine with 1 in 200,000 epinephrine infusion will be administered at a rate of 2-10 ml/hour adjusted according to patient's blood pressure. After the surgery, 0.125% levobupivacaine with 2.5μg fentanyl and 1 in 400,000 epinephrine will be administered at the rate of 0.10-0.15 ml kg-1 h-1 (0.5 h lock and 2 ml bolus) through a patient-controlled infusion pump. Ultrasound-guided (USG) subcostal TAP block will be performed at the end of surgery. Fifteen milliliters of 0.5% levobupivacaine with 1 in 400,000 epinephrine will be injected in incremental doses on each side of the abdomen. Epidural continuous epidural infusion Epidural catheters will be applied at the T6-8 level prior to the induction. 6 ml of 2% xylocaine with 1 in 200,000 epinephrine administered before surgery. During the surgery, 2% xylocaine with 1 in 200,000 epinephrine infusion will be administered at a rate of 2-10 ml/hour adjusted according to patient's blood pressure. After surgery, 0.125% levobupivacaine with 2.5μg fentanyl and 1 in 400,000 epinephrine will be given at a rate of 0.10-0.15 ml kg-1 h-1 (0.5 h lock and 2 ml bolus) through a patient-controlled infusion pump.
- Primary Outcome Measures
Name Time Method Intraoperative hypotension ( > 30% decline in the preoperative systolic/diastolic blood pressure) during operation
- Secondary Outcome Measures
Name Time Method NRS pain score postoperative day 0 to 4
Trial Locations
- Locations (1)
Koo Foundation Sun Yat-Sen Cancer Center
🇨🇳Taipei, Taiwan